Cynata Therapeutics - Company & Market Research Reports

Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus, using discoveries made at the University of Wisconsin-Madison (UWM). The Cymerus platform technology is based upon stem cells known as mesenchymoangioblasts (MCAs). MCAs are a precursor of mesenchymal stem (or stromal) cells (MSCs), which are at the forefront of a new generation of treatments being investigated for such devastating diseases as osteoarthritis, Crohn's disease and heart disease.

From
From
From
From
From
From
From
From
From
From
From
From
Cynata Therapeutics Ltd - Product Thumbnail Image

Cynata Therapeutics Ltd

  • Company Profile
  • 72 Pages
  • 16 Results (Page 1 of 1)
Loading Indicator
adroll